Metaraminol Bitartrate

Spécifications

33402-03-8Numéro CAS

251-502-3Numéro CE

3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol;(2R,3R)-2,3-dihydroxybutanedioic acidNom IUPAC

C13H19NO8Formule chimique

317.29 g/molMasse molaire

Metaraminol bitartrate; 33402-03-8; Metaraminol Tartrate; ZC4202M9P3; NSC-758425; DTXCID9025580; DTXSID1045580; Metaraminol hydrochloride, (-)-; Tartrate, Metaraminol; Bitartrate, Metaraminol; RefChem:56695; Metaraminol Bitartrate (1:1); Aramine; CHEBI:6795; Metaraminol (+)-bitartrate salt; Araminum; Levicor; Metaramin; Levicor ampullen; Araminum ampullen; l-Metraminol bitartrate; Aramine (sympathominetic); (-)-Metaraminol bitartrate; Metaraminol tartrate (1:1); UNII-ZC4202M9P3; Metaraminol (tartrate); IMS metaraminol bitartrat ampullen; Metaraminol (R,R)-hydrogentartrat; Metaraminol bitartrate [USP:JAN]; Metaraminol hydrogen (+)-tartrate; EINECS 251-502-3; Benzenemethanol, a-[(1S)-1-aminoethyl]-3-hydroxy-, (aR)-,(2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt); 3-((1R,2S)-2-amino-1-hydroxypropyl)phenol (2R,3R)-2,3-dihydroxysuccinate; NSC 758425; 1-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol bitartrate; (-)-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol bitartrate; l-1-(m-Hydroxyphenyl)-2-amino-1-propanol-d-hydrogen tartrate; 1-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol hydrogen d-tartrate; Metaraminol bitartrate (hydrogen l-tartrate); (-)-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol tartrate (1:1) (salt); Benzyl alcohol, alpha-(1-aminoethyl)-m-hydroxy-, (-)-, tartrate (1:1) (salt); Benzenemethanol, alpha-(1-aminoethyl)-3-hydroxy-, (R-(R*,S*))-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt); BENZYL ALCOHOL, alpha-(1-AMINOETHYL)-m-HYDROXY-, TARTRATE (1:1), D-(-)-; Benzenemethanol, alpha-((1S)-1-aminoethyl)-3-hydroxy-, (alphaR)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1); MFCD00238763; Aramine (TN); Metaraminol bitatrate; Prestwick3_000197; METARADRINE BITARTRATE; BSPBio_000153; BSPBio_003506; BPBio1_000169; orb1225271; orb1310764; SCHEMBL30261865; VENXSELNXQXCNT-IJYXXVHRSA-N; HMS2093A03; HMS3885J21; Metaraminol bitartrate (JAN/USP); MSK164108X; Pharmakon1600-01503251; METARAMINOL BITARTRATE [MI]; EX-A1348; HY-B1116; METARAMINOL BITARTRATE [JAN]; EBC-04139; METARAMINOL TARTRATE [MART.]; NSC758425; METARAMINOL BITARTRATE [VANDF]; METARAMINOL TARTRATE [WHO-DD]; AKOS037515726; CCG-213141; CS-4715; METARAMINOL BITARTRATE [USP-RS]; AC-33541; BM166414; FM183787; Metaraminol bitatrate - Bio-X trade mark; METARAMINOL BITARTRATE [ORANGE BOOK]; METARAMINOL BITARTRATE [USP IMPURITY]; METARAMINOL BITARTRATE [USP MONOGRAPH]; D01019; F18205; METARAMINOL BITARTRATE, (R-(R*,S*))-; SR-05000001611; SR-05000001611-1; Q27107333; Z2050038784; Metaraminol bitartrate, United States Pharmacopeia (USP) Reference Standard; (-)-.ALPHA.-(1-AMINOETHYL)-M-HYDROXYBENZYL ALCOHOL TARTRATE (1:1) (SALT); 3-[(1R,2S)-2-amino-1-hydroxy-propyl]phenol;(2R,3R)-2,3-dihydroxybutanedioic acidSynonymes